AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tonyt who wrote (792)	9/12/1997 10:02:00 AM
From: Henry Niman	of 2173

Tony, Mentions on CNBC are great for exposure and generally lead to a temporary gain in price and volume. I did comment that AMLN and ISIP had the graphics, so they were most likely to move. I didn't really hear anything new in McCamant's remarks (if I missed something new, why don't you post it and I'll comment) and per your request: techstocks.com , I did comment on the clinicals when they came out. This morning there was a request to discuss AMLN as an investment: techstocks.com I have commented on that in the past also, although that's really not my area of expertise. I put up the paragraph from thestreet because it focused on the investment aspect and I didn't think that that area was discussed much on this thread.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next